title: In vitro response of prostaglandin E2 receptor (EP3) in the term pregnant rat uterus and cervix to misoprostol.
abstract: We examined and compared the in vitro effects of misoprostol (synthetic prostaglandin E1 (PGE1) analogue) on prostaglandin E2 (PGE2) secretion and EP3 receptor mRNA expression in the pregnant rat myometrium and cervix at 19 days gestation. Myometrial and cervical tissue samples were exposed to media with or without misoprostol (50 or 100 pg/ml) and incubated for 15 and 30 min, and 1, 3, 6, 12, and 24 h. Media and tissue samples were collected for quantification of PGE2 and mRNA expression of rEP3alpha and rEP3beta receptor, respectively. PGE2 secretion increased (P < or = 0.05) in the myometrium exposed to 50 and 100 pg/ml misoprostol. Cervical PGE2 secretion increased following exposure to the 100 pg/ml dose only. In the myometrium, 50 and 100 pg/ml misoprostol induced elevations in rEP3alpha and rEP3beta receptor mRNA expression. rEP3alpha and rEP3beta receptor mRNA expression in the cervix was not different from controls. These data demonstrate that the EP3 receptor is differentially expressed in the myometrium and cervix in response to misoprostol. This may account for the ability of misoprostol to stimulate the myometrium when administered for cervical ripening.
authors.affiliation: Division of Perinatal Medicine, Women's Hospital, Long Beach Memorial Medical Center, Long Beach, CA, USA.
authors.forename: Cecilia
authors.initials: C
authors.lastname: Lyons
authors.forename: Kay
authors.initials: K
authors.lastname: Beharry
authors.forename: Yasir
authors.initials: Y
authors.lastname: Akmal
authors.forename: Frank
authors.initials: F
authors.lastname: Attenello
authors.forename: Michael P
authors.initials: MP
authors.lastname: Nageotte
mesh_terms: D000818:Animals; D002584:Cervix Uteri / Q000187:drug effects*; D003720:Densitometry; D015232:Dinoprostone / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D016595:Misoprostol / Q000494:pharmacology*; D009215:Myometrium / Q000187:drug effects; D010120:Oxytocics / Q000494:pharmacology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018078:Receptors, Prostaglandin E / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014599:Uterus / Q000187:drug effects*
chemical_list: D010120:Oxytocics; D012333:RNA, Messenger; D018078:Receptors, Prostaglandin E; D016595:Misoprostol; D012313:RNA; D015232:Dinoprostone